GCKR and metabolic dysfunction-associated steatotic liver disease: Our study is the first large population-based study investigating the association of six genetic variants increasing (PNPLA3, TM6SF2, GCKR, MBOAT7) and two genetic variants decreasing (PPP1R3B, HDS17B13) the risk of NAFLD.